Vivani Medical, Inc. (VANI)

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

1.25 on 9 Oct 2026

13 buys0 sales at will0 planned sales

Fiscal year 2025, ended 31 Dec 2025, as filed

Revenue

$0.00

Net income

$26.61M

Free cash flow

$25.49M

Return on equity

-169.2%

Return on capital

-138.4%

Fiscal years, as filed with the SEC · point at a year for the detail

RevenueNet incomeLoss

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
15 Jul 2026	Williams Gregg Director	Bought	$1,000.00K	2.2%
15 Jun 2026	Williams Gregg Director	Bought	$2.00M	4.6%
15 May 2026	Williams Gregg Director	Bought	$2.00M	4.8%
15 Apr 2026	Williams Gregg Director	Bought	$2.00M	5.1%
15 Mar 2026	Williams Gregg Director	Bought	$1.68M	5.3%
15 Feb 2026	Williams Gregg Director	Bought	$1.98M	6.7%

33out of 100

Profitability 0

Financial strength 34

Growth n/a

Insiders 83

Strongest on insiders (83), weakest on profitability (0). A score of the business, not of the price.

Last 12 months

Only here

Bought

$26.62M

13 buys, 2 buyers

Sold

$0.00

0 sales

Planned sales

n/a

under a 10b5-1 plan